_id
691844ff3c536f8df2317757
Ticker
XRTX
Name
XORTX Therapeutics Inc
Exchange
NASDAQ
Address
3710 ? 33rd Street NW, Calgary, AB, Canada, T2L 2M1
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.xortx.com
Description
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.
Last Close
0.6
Volume
24207
Current Price
0.6
Change
-5.834874726752977
Last Updated
2026-01-08T13:09:37.017Z
Image
https://logo.clearbit.com/www.xortx.com
Ipo Date
2018-11-28T00:00:00.000Z
Market Cap
4177331
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.995
Sentiment Sources
1
Rating
5
Target Price
13.8771
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
29059
Gross Profit
-29059
Operating Expenses
679197
Operating Income
-708257
Interest Expense
-
Pretax Income
-642268
Net Income
-642268
Eps
-0.1322493412427445
Dividends Per Share
-
Shares Outstanding
6962218
Income Tax Expense
-
EBITDA
-613209
Operating Margin
-
Total Other Income Expense Net
65988
Cash
1661273
Short Term Investments
-
Receivables
30781
Inventories
-
Total Current Assets
1736766
Property Plant Equipment
83046
Total Assets
3916871
Payables
942448
Short Term Debt
82226
Long Term Debt
-
Total Liabilities
1165211
Equity
2746263
Bs_currency_symbol
USD
Depreciation
29059
Change In Working Capital
53631
Cash From Operations
-620871
Capital Expenditures
5486
Cash From Investing
-5310
Cash From Financing
773744
Net Change In Cash
126908
Cf_currency_symbol
USD
PE
-
PB
1.0610403300776363
ROE
-23.386980780791937
ROA
-16.397476455058133
FCF
-626357
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
29059
Quarters > 0 > income Statement > gross Profit
-29059
Quarters > 0 > income Statement > operating Expenses
679197
Quarters > 0 > income Statement > operating Income
-708257
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-642268
Quarters > 0 > income Statement > net Income
-642268
Quarters > 0 > income Statement > eps
-0.1322493412427445
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4856493
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-613209
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
65988
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1661273
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
30781
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1736766
Quarters > 0 > balance Sheet > property Plant Equipment
83046
Quarters > 0 > balance Sheet > total Assets
3916871
Quarters > 0 > balance Sheet > payables
942448
Quarters > 0 > balance Sheet > short Term Debt
82226
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1165211
Quarters > 0 > balance Sheet > equity
2746263
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-642268
Quarters > 0 > cash Flow > depreciation
29059
Quarters > 0 > cash Flow > change In Working Capital
53631
Quarters > 0 > cash Flow > cash From Operations
-620871
Quarters > 0 > cash Flow > capital Expenditures
5486
Quarters > 0 > cash Flow > cash From Investing
-5310
Quarters > 0 > cash Flow > cash From Financing
773744
Quarters > 0 > cash Flow > net Change In Cash
126908
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.1322493412427445
Quarters > 0 > ratios > PB
1.0610403300776363
Quarters > 0 > ratios > ROE
-23.386980780791937
Quarters > 0 > ratios > ROA
-16.397476455058133
Quarters > 0 > ratios > FCF
-626357
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
28085
Quarters > 1 > income Statement > gross Profit
-28085
Quarters > 1 > income Statement > operating Expenses
876523
Quarters > 1 > income Statement > operating Income
-904608
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-729525
Quarters > 1 > income Statement > net Income
-729525
Quarters > 1 > income Statement > eps
-0.192575930918953
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3788246
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-701441
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
175083
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1063477
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
10860
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1264520
Quarters > 1 > balance Sheet > property Plant Equipment
82490
Quarters > 1 > balance Sheet > total Assets
2742018
Quarters > 1 > balance Sheet > payables
356405
Quarters > 1 > balance Sheet > short Term Debt
80473
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
711455
Quarters > 1 > balance Sheet > equity
2030563
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-717700
Quarters > 1 > cash Flow > depreciation
27630
Quarters > 1 > cash Flow > change In Working Capital
65807
Quarters > 1 > cash Flow > cash From Operations
-793519
Quarters > 1 > cash Flow > capital Expenditures
21825
Quarters > 1 > cash Flow > cash From Investing
-21825
Quarters > 1 > cash Flow > cash From Financing
-43444
Quarters > 1 > cash Flow > net Change In Cash
-831761
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.192575930918953
Quarters > 1 > ratios > PB
1.1193681752302194
Quarters > 1 > ratios > ROE
-35.92722806433486
Quarters > 1 > ratios > ROA
-26.605405216158317
Quarters > 1 > ratios > FCF
-815344
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
25906
Quarters > 2 > income Statement > gross Profit
-25906
Quarters > 2 > income Statement > operating Expenses
934638
Quarters > 2 > income Statement > operating Income
-960544
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-696561
Quarters > 2 > income Statement > net Income
-696561
Quarters > 2 > income Statement > eps
-0.18639073442221657
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3737101
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-670655
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
263982
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1895238
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
17252
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2103439
Quarters > 2 > balance Sheet > property Plant Equipment
15257
Quarters > 2 > balance Sheet > total Assets
3498668
Quarters > 2 > balance Sheet > payables
354037
Quarters > 2 > balance Sheet > short Term Debt
15662
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
757350
Quarters > 2 > balance Sheet > equity
2741318
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-698673
Quarters > 2 > cash Flow > depreciation
25985
Quarters > 2 > cash Flow > change In Working Capital
266942
Quarters > 2 > cash Flow > cash From Operations
-643730
Quarters > 2 > cash Flow > capital Expenditures
3385
Quarters > 2 > cash Flow > cash From Investing
-3385
Quarters > 2 > cash Flow > cash From Financing
67577
Quarters > 2 > cash Flow > net Change In Cash
-578411
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.18639073442221657
Quarters > 2 > ratios > PB
0.8179498328906023
Quarters > 2 > ratios > ROE
-25.40971167883478
Quarters > 2 > ratios > ROA
-19.90931977541167
Quarters > 2 > ratios > FCF
-647115
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
25406
Quarters > 3 > income Statement > gross Profit
-25406
Quarters > 3 > income Statement > operating Expenses
617196
Quarters > 3 > income Statement > operating Income
-642602
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
119076
Quarters > 3 > income Statement > net Income
119076
Quarters > 3 > income Statement > eps
0.03887085322560901
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3063375
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
144482
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
761678
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2472177
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
17626
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2675105
Quarters > 3 > balance Sheet > property Plant Equipment
34700
Quarters > 3 > balance Sheet > total Assets
4092091
Quarters > 3 > balance Sheet > payables
84020
Quarters > 3 > balance Sheet > short Term Debt
38761
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
757539
Quarters > 3 > balance Sheet > equity
3334552
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
119076
Quarters > 3 > cash Flow > depreciation
25406
Quarters > 3 > cash Flow > change In Working Capital
-256069
Quarters > 3 > cash Flow > cash From Operations
-865780
Quarters > 3 > cash Flow > capital Expenditures
2.27
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1067020
Quarters > 3 > cash Flow > net Change In Cash
172902
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.03887085322560901
Quarters > 3 > ratios > PB
0.5512059790940432
Quarters > 3 > ratios > ROE
3.570974451740444
Quarters > 3 > ratios > ROA
2.9099059625018113
Quarters > 3 > ratios > FCF
-865782.27
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
62
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3593464
Annuals > 0 > income Statement > operating Income
-3593464
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-4763564
Annuals > 0 > income Statement > net Income
-4763564
Annuals > 0 > income Statement > eps
-1.6548691442876429
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2878514
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3706359
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1170099
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2473649
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
17637
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2676698
Annuals > 0 > balance Sheet > property Plant Equipment
34721
Annuals > 0 > balance Sheet > total Assets
4094527
Annuals > 0 > balance Sheet > payables
84020
Annuals > 0 > balance Sheet > short Term Debt
38785
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
757990
Annuals > 0 > balance Sheet > equity
3336537
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3313346
Annuals > 0 > cash Flow > depreciation
117274
Annuals > 0 > cash Flow > change In Working Capital
116793
Annuals > 0 > cash Flow > cash From Operations
-3678648
Annuals > 0 > cash Flow > capital Expenditures
38924
Annuals > 0 > cash Flow > cash From Investing
-38924
Annuals > 0 > cash Flow > cash From Financing
2779509
Annuals > 0 > cash Flow > net Change In Cash
-974016
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.6548691442876429
Annuals > 0 > ratios > PB
0.5176350209813348
Annuals > 0 > ratios > ROE
-142.7697040374496
Annuals > 0 > ratios > ROA
-116.33978723305525
Annuals > 0 > ratios > FCF
-3717572
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
142255
Annuals > 1 > income Statement > gross Profit
-142255
Annuals > 1 > income Statement > operating Expenses
6014606
Annuals > 1 > income Statement > operating Income
-6156862
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-2197641
Annuals > 1 > income Statement > net Income
-2197641
Annuals > 1 > income Statement > eps
-1.1089485268961425
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1981734
Annuals > 1 > income Statement > income Tax Expense
-0.01
Annuals > 1 > income Statement > EBITDA
-2055384
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
3959220
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3447665
Annuals > 1 > balance Sheet > short Term Investments
-24797
Annuals > 1 > balance Sheet > receivables
60711
Annuals > 1 > balance Sheet > inventories
247944
Annuals > 1 > balance Sheet > total Current Assets
4068783
Annuals > 1 > balance Sheet > property Plant Equipment
23927
Annuals > 1 > balance Sheet > total Assets
5467964
Annuals > 1 > balance Sheet > payables
195814
Annuals > 1 > balance Sheet > short Term Debt
11510
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
825938
Annuals > 1 > balance Sheet > equity
4642026
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2158065
Annuals > 1 > cash Flow > depreciation
105179
Annuals > 1 > cash Flow > change In Working Capital
-1030741
Annuals > 1 > cash Flow > cash From Operations
-6583165
Annuals > 1 > cash Flow > capital Expenditures
47114.33
Annuals > 1 > cash Flow > cash From Investing
-46363
Annuals > 1 > cash Flow > cash From Financing
-361044
Annuals > 1 > cash Flow > net Change In Cash
-6986531
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.1089485268961425
Annuals > 1 > ratios > PB
0.25614686346004956
Annuals > 1 > ratios > ROE
-47.34228115051488
Annuals > 1 > ratios > ROA
-40.1912119392154
Annuals > 1 > ratios > FCF
-6630279.33
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
55525
Annuals > 2 > income Statement > gross Profit
-55525
Annuals > 2 > income Statement > operating Expenses
9818626
Annuals > 2 > income Statement > operating Income
-9874152
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-6997312
Annuals > 2 > income Statement > net Income
-6997312
Annuals > 2 > income Statement > eps
-4.728191454497663
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1479913
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-6941785
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2876839
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
10407841
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
81752
Annuals > 2 > balance Sheet > inventories
-135321
Annuals > 2 > balance Sheet > total Current Assets
10868267
Annuals > 2 > balance Sheet > property Plant Equipment
92491
Annuals > 2 > balance Sheet > total Assets
12343743
Annuals > 2 > balance Sheet > payables
1293807
Annuals > 2 > balance Sheet > short Term Debt
66090
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5368773
Annuals > 2 > balance Sheet > equity
6974970
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-6988880.78
Annuals > 2 > cash Flow > depreciation
55458
Annuals > 2 > cash Flow > change In Working Capital
1449146
Annuals > 2 > cash Flow > cash From Operations
-8818302.39
Annuals > 2 > cash Flow > capital Expenditures
44220.45
Annuals > 2 > cash Flow > cash From Investing
-44220.45
Annuals > 2 > cash Flow > cash From Financing
4738327
Annuals > 2 > cash Flow > net Change In Cash
-3481964
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-4.728191454497663
Annuals > 2 > ratios > PB
0.12730489163394249
Annuals > 2 > ratios > ROE
-100.320316789893
Annuals > 2 > ratios > ROA
-56.68711670358011
Annuals > 2 > ratios > FCF
-8862522.84
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
14137
Annuals > 3 > income Statement > gross Profit
-14137
Annuals > 3 > income Statement > operating Expenses
2871175
Annuals > 3 > income Statement > operating Income
-2885312
Annuals > 3 > income Statement > interest Expense
4425.78
Annuals > 3 > income Statement > pretax Income
-1306294
Annuals > 3 > income Statement > net Income
-1306294
Annuals > 3 > income Statement > eps
-1.1984348623853212
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1090000
Annuals > 3 > income Statement > income Tax Expense
4390.52
Annuals > 3 > income Statement > EBITDA
-1287731
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1579018
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
18803385
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
40654
Annuals > 3 > balance Sheet > inventories
-274057.12
Annuals > 3 > balance Sheet > total Current Assets
20122124
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
21979959
Annuals > 3 > balance Sheet > payables
409658
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5284879
Annuals > 3 > balance Sheet > equity
16695079
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-1295887.12
Annuals > 3 > cash Flow > depreciation
14024
Annuals > 3 > cash Flow > change In Working Capital
-1079794.04
Annuals > 3 > cash Flow > cash From Operations
-4754835.22
Annuals > 3 > cash Flow > capital Expenditures
31222.26
Annuals > 3 > cash Flow > cash From Investing
-31222.26
Annuals > 3 > cash Flow > cash From Financing
19181307
Annuals > 3 > cash Flow > net Change In Cash
14650729
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-1.1984348623853212
Annuals > 3 > ratios > PB
0.03917321984520109
Annuals > 3 > ratios > ROE
-7.824425389062251
Annuals > 3 > ratios > ROA
-5.943113906627397
Annuals > 3 > ratios > FCF
-4786057.4799999995
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.1322493412427445
Valuation > metrics > PB
1.0610403300776363
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-23.386980780791937
Profitability > metrics > ROA
-36.980687093137476
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4242896619879451
Risk > metrics > Interest Coverage
-24.373068584603736
Risk > final Score
-37
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6949449288261438
Liquidity > metrics > Quick Ratio
1.6949449288261438
Liquidity > final Score
92
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
35
Prev Risks > 0
-69
Prev Risks > 1
-88
Prev Risks > 2
-41
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:50:45.900Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.1337
Earnings History > 0 > eps Estimate
-0.316
Earnings History > 0 > eps Difference
0.1823
Earnings History > 0 > surprise Percent
57.6899
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-15
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.19
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.04
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.81
Earnings History > 3 > eps Estimate
-0.41
Earnings History > 3 > eps Difference
-0.4
Earnings History > 3 > surprise Percent
-97.561
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2022
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0586
Earnings History > 5 > eps Estimate
-0.923
Earnings History > 5 > eps Difference
0.9816
Earnings History > 5 > surprise Percent
106.3489
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
1.3504
Earnings History > 6 > eps Estimate
-0.2767
Earnings History > 6 > eps Difference
1.6271
Earnings History > 6 > surprise Percent
588.0376
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.636
Earnings History > 7 > eps Estimate
-0.815
Earnings History > 7 > eps Difference
0.179
Earnings History > 7 > surprise Percent
21.9632
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.67
Earnings History > 8 > eps Estimate
-0.19
Earnings History > 8 > eps Difference
-0.48
Earnings History > 8 > surprise Percent
-252.6316
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.8
Earnings History > 9 > eps Estimate
-1.36
Earnings History > 9 > eps Difference
0.56
Earnings History > 9 > surprise Percent
41.1765
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.11
Earnings History > 10 > eps Estimate
-0.1456
Earnings History > 10 > eps Difference
0.0356
Earnings History > 10 > surprise Percent
24.4505
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.2
Earnings History > 11 > eps Estimate
-0.27
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
25.9259
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.1708
Earnings History > 12 > eps Estimate
-0.1643
Earnings History > 12 > eps Difference
-0.0065
Earnings History > 12 > surprise Percent
-3.9562
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.12
Earnings History > 13 > eps Estimate
-0.24
Earnings History > 13 > eps Difference
0.12
Earnings History > 13 > surprise Percent
50
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.26
Earnings History > 14 > eps Estimate
-0.19
Earnings History > 14 > eps Difference
-0.07
Earnings History > 14 > surprise Percent
-36.8421
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-11-29
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6957
Earnings History > 15 > eps Estimate
-0.0722
Earnings History > 15 > eps Difference
-0.6235
Earnings History > 15 > surprise Percent
-863.5734
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-08-27
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.019
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-04-27
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.2085
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-12-31
Earnings History > 18 > report Date
2020-12-31
Earnings History > 18 > date
2020-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.4522
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-09-30
Earnings History > 19 > report Date
2020-11-30
Earnings History > 19 > date
2020-09-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0461
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-06-30
Earnings History > 20 > report Date
2020-08-31
Earnings History > 20 > date
2020-06-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.039
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-03-31
Earnings History > 21 > report Date
2020-06-01
Earnings History > 21 > date
2020-03-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0042
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-12-31
Earnings History > 22 > report Date
2019-12-31
Earnings History > 22 > date
2019-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.241
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-09-30
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.1677
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-06-30
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.1951
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-03-31
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.1931
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2018-12-31
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.1875
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AXortx Therapeutics: Micro-cap roller coaster as XRTX tests the patience of speculative biotech inves AD HOC NEWS
Read more →Quarterly Earnings: What is APOGs valuation compared to sector - Weekly Trend Report & AI Forecast Swing Trade Picks baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$13.8771
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 1.15% of the total shares of XORTX Therapeutics Inc
1.
Citadel Advisors Llc(0.738%)
since
2025/06/30
2.
UBS Group AG(0.3989%)
since
2025/06/30
3.
Royal Bank of Canada(0.0127%)
since
2025/06/30
4.
Hartland & Co(0.0053%)
since
2025/06/30
5.
Armistice Capital, LLC(0%)
since
2025/03/31
6.
Advisor Group Holdings, Inc.(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.1337
EPS Estimate
-0.316
EPS Difference
0.1823
Surprise Percent
57.6899%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.